| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
|
J Clin Oncol
|
2006
|
2.68
|
|
2
|
Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.
|
Clin Cancer Res
|
2011
|
2.31
|
|
3
|
In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival.
|
Thyroid
|
2012
|
1.64
|
|
4
|
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
|
Carcinogenesis
|
2005
|
1.61
|
|
5
|
Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.
|
J Clin Oncol
|
2007
|
1.61
|
|
6
|
BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.
|
Cancer Res
|
2004
|
1.58
|
|
7
|
Human tracheal reconstruction with a composite radial forearm free flap and prosthesis.
|
Ann Thorac Surg
|
2006
|
1.46
|
|
8
|
Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
|
Cancer
|
2004
|
1.43
|
|
9
|
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
|
J Biol Chem
|
2006
|
1.31
|
|
10
|
The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
|
Clin Cancer Res
|
2004
|
1.30
|
|
11
|
High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.
|
Clin Cancer Res
|
2009
|
1.29
|
|
12
|
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
|
Laryngoscope
|
2005
|
1.27
|
|
13
|
Elective and therapeutic selective neck dissection.
|
Oral Oncol
|
2005
|
1.26
|
|
14
|
A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
|
Cancer
|
2002
|
1.22
|
|
15
|
Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
|
J Invest Dermatol
|
2007
|
1.19
|
|
16
|
An orthotopic model of papillary thyroid carcinoma in athymic nude mice.
|
Arch Otolaryngol Head Neck Surg
|
2008
|
1.19
|
|
17
|
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
|
Head Neck
|
2009
|
1.17
|
|
18
|
Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma.
|
Arch Otolaryngol Head Neck Surg
|
2003
|
1.15
|
|
19
|
p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
|
Clin Cancer Res
|
2003
|
1.13
|
|
20
|
Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
|
Clin Cancer Res
|
2004
|
1.13
|
|
21
|
Recent advances in thyroid cancer.
|
Curr Probl Surg
|
2008
|
1.09
|
|
22
|
MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo.
|
Mol Cancer Ther
|
2010
|
1.08
|
|
23
|
Parathyroid carcinoma: a 22-year experience.
|
Head Neck
|
2004
|
1.08
|
|
24
|
A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma.
|
Arch Otolaryngol Head Neck Surg
|
2002
|
1.08
|
|
25
|
Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.
|
J Invest Dermatol
|
2006
|
1.08
|
|
26
|
Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
|
Cancer
|
2010
|
1.06
|
|
27
|
Fenretinide activity in retinoid-resistant oral leukoplakia.
|
Clin Cancer Res
|
2006
|
1.06
|
|
28
|
Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics.
|
Clin Cancer Res
|
2010
|
1.02
|
|
29
|
Predictors of level V metastasis in well-differentiated thyroid cancer.
|
Head Neck
|
2008
|
1.01
|
|
30
|
SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
|
J Invest Dermatol
|
2004
|
1.01
|
|
31
|
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.
|
Clin Cancer Res
|
2007
|
0.99
|
|
32
|
Simultaneous reconstruction of the posterior pharyngeal wall and cervical spine with a free vascularized fibula osteocutaneous flap.
|
Plast Reconstr Surg
|
2002
|
0.98
|
|
33
|
Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
|
Mol Cancer Ther
|
2003
|
0.98
|
|
34
|
Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
|
Biol Chem
|
2005
|
0.98
|
|
35
|
Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis.
|
Biochemistry
|
2003
|
0.96
|
|
36
|
Management of the N0 neck--reference or preference.
|
Oral Oncol
|
2005
|
0.95
|
|
37
|
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.
|
Am J Pathol
|
2011
|
0.95
|
|
38
|
Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
|
Arch Otolaryngol Head Neck Surg
|
2007
|
0.95
|
|
39
|
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
|
J Clin Oncol
|
2006
|
0.94
|
|
40
|
Transoral resection of thyroid cancer metastasis to lateral retropharyngeal nodes.
|
Head Neck
|
2007
|
0.93
|
|
41
|
Changing concepts in the surgical management of the cervical node metastasis.
|
Oral Oncol
|
2003
|
0.93
|
|
42
|
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
|
J Natl Cancer Inst
|
2005
|
0.92
|
|
43
|
Preoperative lateral neck ultrasonography as a long-term outcome predictor in papillary thyroid cancer.
|
Arch Otolaryngol Head Neck Surg
|
2011
|
0.91
|
|
44
|
Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma.
|
Head Neck
|
2008
|
0.91
|
|
45
|
Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification.
|
Oncogene
|
2002
|
0.91
|
|
46
|
The effect of cyclin D1 overexpression in human head and neck cancer cells.
|
Eur Arch Otorhinolaryngol
|
2004
|
0.90
|
|
47
|
Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution.
|
Arch Biochem Biophys
|
2005
|
0.89
|
|
48
|
New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.
|
J Proteome Res
|
2010
|
0.89
|
|
49
|
Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation.
|
Oncogene
|
2003
|
0.89
|
|
50
|
Detection of thyroid cancer stem cells in papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2013
|
0.88
|
|
51
|
Elevated human tissue kallikrein levels in the stratum corneum and serum of peeling skin syndrome-type B patients suggests an over-desquamation of corneocytes.
|
J Invest Dermatol
|
2006
|
0.88
|
|
52
|
Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
|
Hum Pathol
|
2007
|
0.88
|
|
53
|
Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
|
Protein Expr Purif
|
2004
|
0.88
|
|
54
|
4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis.
|
J Invest Dermatol
|
2006
|
0.88
|
|
55
|
Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
|
Head Neck
|
2008
|
0.87
|
|
56
|
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma.
|
Cancer
|
2007
|
0.87
|
|
57
|
Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
|
Ann Surg Oncol
|
2009
|
0.87
|
|
58
|
Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis.
|
Arch Biochem Biophys
|
2003
|
0.86
|
|
59
|
Treatment considerations for head and neck cancer in the elderly.
|
J Laryngol Otol
|
2005
|
0.86
|
|
60
|
Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis.
|
Clin Cancer Res
|
2002
|
0.85
|
|
61
|
Serum squamous cell carcinoma antigen is a useful biologic marker in patients with inverted papillomas of the sinonasal tract.
|
Cancer
|
2002
|
0.85
|
|
62
|
Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.
|
Arch Otolaryngol Head Neck Surg
|
2009
|
0.84
|
|
63
|
Headpin: a serpin with endogenous and exogenous suppression of angiogenesis.
|
Cancer Res
|
2005
|
0.83
|
|
64
|
Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma.
|
Hum Pathol
|
2009
|
0.83
|
|
65
|
Stent fabrication for graft immobilization following wide surgical excision of myofibroblastic sarcoma of the buccal mucosa: a clinical report.
|
J Prosthet Dent
|
2006
|
0.83
|
|
66
|
Use of transoral sonography with an endocavitary transducer in diagnosis, fine-needle aspiration biopsy, and intraoperative localization of retropharyngeal masses.
|
AJR Am J Roentgenol
|
2014
|
0.81
|
|
67
|
Src inhibitors in suppression of papillary thyroid carcinoma growth.
|
Head Neck
|
2013
|
0.80
|
|
68
|
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.
|
Surgery
|
2012
|
0.80
|
|
69
|
Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.
|
Hum Pathol
|
2011
|
0.79
|
|
70
|
Long-term outcomes of microsurgical reconstruction for large tracheal defects.
|
Cancer
|
2010
|
0.78
|
|
71
|
Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer.
|
Exp Biol Med (Maywood)
|
2009
|
0.78
|
|
72
|
Production of serpins using baculovirus expression systems.
|
Methods
|
2004
|
0.78
|
|
73
|
Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.
|
Clin Chim Acta
|
2006
|
0.78
|
|
74
|
Is there a role for selective neck dissection after chemoradiation for head and neck cancer?
|
J Am Coll Surg
|
2004
|
0.78
|
|
75
|
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
|
Thyroid
|
2009
|
0.77
|
|
76
|
LBP-1b, LBP-9, and LBP-32/MGR detected in syncytiotrophoblasts from first-trimester human placental tissue and their transcriptional regulation.
|
DNA Cell Biol
|
2008
|
0.77
|
|
77
|
Development and characterization of six new human papillary thyroid carcinoma cell lines.
|
J Clin Endocrinol Metab
|
2014
|
0.76
|
|
78
|
Recent advances in thyroid cancer. In brief.
|
Curr Probl Surg
|
2008
|
0.75
|
|
79
|
Surgical management of recurrent thyroid cancer.
|
Neuroimaging Clin N Am
|
2008
|
0.75
|
|
80
|
The identification of a new role for LEKTI in the skin: The use of protein 'bait' arrays to detect defective trafficking of dermcidin in the skin of patients with Netherton syndrome.
|
J Proteomics
|
2012
|
0.75
|
|
81
|
New and emerging therapeutic options for thyroid carcinoma.
|
Clin Adv Hematol Oncol
|
2015
|
0.75
|